Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $1.05 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 80.95%. A quarter ago, it was expected that this company would post a loss of $0.12 per share when it actually produced earnings of $0.03, delivering a surprise of 125%.
Over the last four quarters,…